Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Malebogo M. Moremane"'
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 8, Pp 6880-6902 (2023)
The global burden of female breast cancer and associated deaths has become a major concern. Many chemotherapeutic agents, such as doxorubicin, have been shown to have adverse side effects. The development of multi-drug resistance is a common occurren
Externí odkaz:
https://doaj.org/article/ce6aeb8dcfc44ba5a97a5043e62cd526
Autor:
Sangweni NF; Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg, South Africa.; Division of Medical Physiology, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa., Moremane M; Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg, South Africa.; Division of Medical Physiology, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa., Riedel S; Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg, South Africa.; Division of Medical Physiology, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa., van Vuuren D; Division of Medical Physiology, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa., Huisamen B; Division of Medical Physiology, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa., Mabasa L; Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg, South Africa., Barry R; Research and Development Department, Biopharm, Hamilton, New Zealand., Johnson R; Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg, South Africa.; Division of Medical Physiology, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2020 Aug 05; Vol. 11, pp. 1172. Date of Electronic Publication: 2020 Aug 05 (Print Publication: 2020).